|
BNTC | Benitec Biopharma Inc. |
|
|
BNTC | Benitec Biopharma Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 2.60 |
| Leverage | 3.95% |
| Market Cap | $ 29.2m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -21.3m |
| Margin | 12392.29% |
Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California.